trimethyloxamine has been researched along with amyloid beta-peptides in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chakrabartty, A; Fraser, PE; Huang, TH; Yang, DS; Yip, CM | 1 |
Fernandez, EJ; Good, TA; Qi, W; Zhang, A | 1 |
Asthana, S; Bendlin, BB; Blennow, K; Carlsson, CM; Darst, BF; Engelman, CD; Johnson, SC; Rey, FE; Romano, KA; Vogt, NM; Zetterberg, H | 1 |
3 other study(ies) available for trimethyloxamine and amyloid beta-peptides
Article | Year |
---|---|
Manipulating the amyloid-beta aggregation pathway with chemical chaperones.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Circular Dichroism; Fluorescent Dyes; Glycerol; Humans; Methylamines; Microscopy, Atomic Force; Microscopy, Electron; Molecular Chaperones; Peptide Fragments; Protein Conformation; Protein Folding; Protein Structure, Secondary; Solubility; Spectrometry, Fluorescence | 1999 |
Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability.
Topics: Amyloid beta-Peptides; Congo Red; Liposomes; Membranes, Artificial; Methylamines; Molecular Weight; Neurotoxins; Peptide Fragments; Sucrose; Trehalose | 2009 |
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Gastrointestinal Microbiome; Humans; Male; Methylamines; Middle Aged; Peptide Fragments; tau Proteins | 2018 |